Find out what Breast Cancer Care is saying about the latest drug treatments, research papers and health policy issues.

If you’re working on a story and need an expert quote, call us on 0345 092 0807 (out of hours 07702 901 334).

Responding to NHS England’s Cancer Waiting Times for July 2018, Gunes Kalkan, Head of Evidence, Policy and Campaigns at Breast Cancer Care, says:...

Responding to an announcement from Jeane Freeman MSP, Health Secretary, revealing that 1,761 women aged over 71 in Scotland were not invited for their...

Responding to a new online tool that could better predict the long-term risk of oestrogen receptor positive breast cancer returning and the need for...

Responding to the updated draft guidance from NICE to not recommend Perjeta (pertuzumab) for routine NHS use after surgery for early HER2-positive breast...

Responding to news that health officials are investigating concerns that adults who should have been invited for breast and bowel cancer screening may...

Discussing the news that NHS trusts are being encouraged to move away from the breast cancer drug Herceptin to use a biologically similar medicine,...

Responding to the publication of NICE’s updated guidance for early and locally advanced breast cancer, Samia al Qadhi, Chief Executive of Breast Cancer...

Responding to the news that flight attendants are more likely to develop several forms of cancer than the average person, Addie Mitchell, Clinical Nurse...

Responding to new evidence from the Institute of Cancer Research suggesting that higher BMIs in young women reduce their risk of breast cancer, Rachel...

Responding to a new review by the Royal College of Surgeons and the Association of Breast Surgery revealing that older women are less likely to receive...